Mortality trends for acute pancreatitis during the COVID-19 pandemic in the US

2024-9-11

Cost-effectiveness of operative intervention for mucinous cystic neoplasm: the role of post-operative diabetes

2024-9-11

Tumor immune microenvironment promotes cachexia in pancreatic cancer

2024-9-11

Increased PRIM2 expression associated with poor-prognosis in patients with pancreatic ductal adenocarcinoma

2024-9-11

PATIENT AND FAMILY INPUT TO DETERMINE EXPERIENCES AND RESEARCH INTERESTS IN PEDIATRIC PANCREATITIS: AN INSPPIRE-2 STUDY

2024-9-11

Risk factors and a prediction model for pain recurrence after pancreatic stent removal in painful chronic pancreatitis

2024-9-11

Characterization of Human Pancreatic Islet Cells using a Single-Cell Western Blot Platform

2024-9-11

Individualized Pain Treatment in Chronic Pancreatitis (INPAIN): An International, Multicenter, Investigator-initiated, Prospective, Cohort Study

2024-9-11

ICD-10 Diagnosis Codes are Over-Utilized in the Diagnosis of Chronic Pancreatitis

2024-8-12

Systematic Review of Volume and Methodological Quality of Randomised Trials in Acute Pancreatitis

2024-8-12

Effect of Radiotherapy in Neoadjuvant Treatment of Borderline Resectable and Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis

2024-8-12

Combined EUS and ERCP in patients with malignant distal biliary obstruction is associated with reduced time to oncological therapy compared to ERCP and sampling alone

2024-8-7

Risk factors of negative diagnosis of MRCP in acute biliary pancreatitis patients with choledocholithiasis

2024-8-6

Preoperative chemotherapy with Gemcitabine for pancreatic cancer causes zinc deficiency

2024-8-6

Incidence and Effect Duration of Immune Checkpoint Inhibitor-Related Pancreas Adverse Events

2024-8-1

The Potential Clinical Benefits of Direct Surgical Transgastric Pancreatic Necrosectomy for Patients With Infected Necrotizing Pancreatitis

2024-8-1

Ex-vivo 3D cellular models of pancreatic ductal adenocarcinoma: from embryonic development to precision oncology

2024-7-30

Risk factors of acute pancreatitis in young adults: a Nationwide population-based cohort study in South Korea

2024-7-29

Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy

2024-7-10

Optimization of Endoscopic Ultrasound Characteristics in the Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasm

2024-7-1

Combined Efficacy of Nimotuzumab and Gemcitabine on the Treatment of Advanced Pancreatic cancer

2024-7-1

Clinical Relevance of Cancerization of Ducts in Resected Pancreatic Ductal Adenocarcinoma

2024-7-1

Multiple Carcinomas In Situ Scattered Throughout the Pancreas Diagnosed by Assessing Focal Pancreatic Parenchymal Atrophy

2024-7-1

The prognostic significance of collagen VI in pancreatic ductal adenocarcinoma

2024-6-25

High dose tacrolimus-induced acute pancreatitis after kidney transplantation: a case report

2024-6-24

Giant Cyst of Intra-Pancreatic Accessory Spleen Mimicking a Malignant Cystic Neoplasm of the Pancreas: a case report

2024-6-21

Financial Toxicity in Patients with Chronic Pancreatitis

2024-6-21

Accurately predict outcomes in acute necrotizing pancreatitis with walled-off necrosis patients

2024-6-4

Increased Gremlin1 Expression in Pancreatic Ductal Adenocarcinoma Promotes a Fibrogenic Stromal Microenvironment

2024-6-4

Agi Hirshberg: Our Lady of Hope

2024-6-3

Total Pancreatectomy with Percutaneous Islet Autotransplant after Remote Islet Processing: A Viable Paradigm?

2024-5-31

Decrease in Bioelectrical Impedance Phase Angle is Associated with Days until Death in Pancreatic Cancer

2024-5-31

ACUTE VENOUS THROMBOEMBOLISM IS COMMON FOLLOWING ACUTE NECROTIZING PANCREATITIS AND IS ASSOCIATED WITH WORSE CLINICAL OUTCOMES

2024-5-31

Real risk Factors for post-ERCP pancreatitis patients

2024-5-17

Commentary on “The serum carbohydrate antigen 19-9 and metabolite hypotaurine are predictive markers for early recurrence of pancreatic ductal adenocarcinoma”

2024-5-17

Evaluation of the Treatment Duration of Japanese Patients With Pancreatic Cancer in a Real-World Setting Using a Large Hospital Claims Database

2024-5-16

Pancreatic body and tail adenocarcinoma: upfront resection versus neoadjuvant therapy, a contemporary analysis

2024-5-15

Genetic assessment of IPMN for predicting concomitant pancreatic ductal adenocarcinoma

2024-5-15

Primary Angiomyolipoma of the Distal Pancreas

2024-5-13

Phenotypic, genomic, and transcriptomic heterogeneity in a pancreatic cancer cell line

2024-5-6

Modulation of nuclear receptor 4A1 expression improves insulin secretion in a mouse model of chronic pancreatitis

2024-5-6

The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and Treatment

2024-5-1

Bile Leak From A Duct of Luschka After Whipple Pancreaticoduodinectomy: A Case Report

2024-5-1

Research progress on the mechanism of acute hypertriglyceridemic pancreatitis

2024-5-1

The role of gut microbiota and innate immune response in an autoimmune pancreatitis model

2024-5-1

Certolizumab has favorable efficacy on preventing pancreas and target organs damage in acute pancreatitis

2024-5-1

Early Hypophosphatemia as a Prognostic Marker in Acute Pancreatitis

2024-5-1

Quality of Life Following TPIAT: A Patient Experience Survey

2024-5-1

Cancer-derived small extracellular vesicles affect vascular endothelial cells and promote adhesiveness of pancreatic cancer cells

2024-5-1

Screening of amino acids as a safe energy source for isolated rat pancreatic acini

2024-5-1